about
Factors associated with positive D-dimer results in patients evaluated for pulmonary embolismCase records of the Massachusetts General Hospital. Case 29-2014. A 60-year-old woman with syncope.Emergency Evaluation for Pulmonary Embolism, Part 1: Clinical Factors that Increase Risk.Pulmonary Hypertension and Right Ventricular Failure in Emergency Medicine.Prospective, randomized evaluation of a personal digital assistant-based research tool in the emergency departmentClinical criteria to prevent unnecessary diagnostic testing in emergency department patients with suspected pulmonary embolism.Risk of thromboembolism following acute intracerebral hemorrhageMeta-analysis of 65,734 individuals identifies TSPAN15 and SLC44A2 as two susceptibility loci for venous thromboembolismContribution of fibrinolysis to the physical component summary of the SF-36 after acute submassive pulmonary embolism.Physical inactivity and idiopathic pulmonary embolism in women: prospective study.Prospective study of the frequency and outcomes of patients with suspected pulmonary embolism administered heparin prior to confirmatory imaging.Prospective Study of Ambient Particulate Matter Exposure and Risk of Pulmonary Embolism in the Nurses' Health Study Cohort.Prospective study of BMI and the risk of pulmonary embolism in women.Evaluation of pulmonary embolism in the emergency department and consistency with a national quality measure: quantifying the opportunity for improvement.Evaluation of older adult patients with falls in the emergency department: discordance with national guidelines.Emergency Evaluation for Pulmonary Embolism, Part 2: Diagnostic Approach.The Massachusetts General Hospital Pulmonary Embolism Response Team (MGH PERT): creation of a multidisciplinary program to improve care of patients with massive and submassive pulmonary embolism.Systematic Molecular Phenotyping: A Path Toward Precision Emergency Medicine?Research Priorities in Submassive Pulmonary Embolism: Proceedings from a Multidisciplinary Research Consensus Panel.Assessment of Right Ventricular Strain by Computed Tomography Versus Echocardiography in Acute Pulmonary Embolism.Multicenter Trial of Rivaroxaban for Early Discharge of Pulmonary Embolism From the Emergency Department (MERCURY PE): Rationale and Design.Clinical gestalt and the diagnosis of pulmonary embolism: does experience matter?A Multidisciplinary Pulmonary Embolism Response Team: Initial 30-Month Experience With a Novel Approach to Delivery of Care to Patients With Submassive and Massive Pulmonary Embolism.A comparison of patients diagnosed with pulmonary embolism who are ≥65 years with patients <65 years.Is there still room for additional common susceptibility alleles for venous thromboembolism?Outcomes considered most important by emergency physicians when determining disposition of patients with pulmonary embolism.Patient preferences for testing for pulmonary embolism in the ED using a shared decision-making model.Rationale and methodology for a multicentre randomised trial of fibrinolysis for pulmonary embolism that includes quality of life outcomes.Pretest probability assessment combined with point-of-care D-dimer testing allows primary care physicians to rule out pulmonary embolism.A multidisciplinary pulmonary embolism response team.Factors associated with clinical deterioration shortly after PE.Acute myocardial infarction after over-the-counter use of pseudoephedrine.Varraso et al. Respond to “Diet and Venous Thromboembolism”.Treatment of submassive pulmonary embolism with tenecteplase or placebo: cardiopulmonary outcomes at 3 months: multicenter double-blind, placebo-controlled randomized trial.What is the effect of venous thromboembolism and related complications on patient reported health-related quality of life? A meta-analysis.Videos in clinical medicine. Orotracheal intubation.Life-threatening flecainide overdose treated with intralipid and extracorporeal membrane oxygenation.Independent evaluation of a simple clinical prediction rule to identify right ventricular dysfunction in patients with shortness of breath.Potential impact of adjusting the threshold of the quantitative D-dimer based on pretest probability of acute pulmonary embolism.Interactions of established risk factors and a GWAS-based genetic risk score on the risk of venous thromboembolism.
P50
Q24633827-7BE14B27-1C7E-4BFC-8215-69783AD259E9Q33164743-2D912E1B-D2CE-463B-B831-D11982B81657Q33165596-C0203699-5AEA-458A-AFF8-AC8A61511C5EQ33166200-3F7ACD8B-18DE-4BAC-9217-65687372BAABQ33315458-07C68FBA-A08D-48C4-8B96-0EF9FE1244C5Q34340059-3CE1933F-58BF-4722-94E5-5192C0FF16C9Q35018742-66FE5AB9-29A7-4C41-9F03-035660BD254DQ35266365-4463B3F1-6B8A-4A6C-B5C4-B8616F03E9E3Q35667701-8F720F72-0A5D-4804-86D3-7FC649DEDCE6Q35699144-1FC17AD8-4706-4FCB-BBCA-B5F02490A084Q35840469-29842FF8-B5BB-4736-AC03-86E83B19D832Q36350827-025E0D0F-52C1-4254-B250-F973A0B08F78Q37162632-75CB8EFC-C4E8-4D8C-A476-1EA49E8A9894Q37176722-F2CF7CCC-F87B-466C-A6C8-58149E6CC3E0Q38379327-04867697-125D-4DC3-B57A-712CEBDA827FQ38387897-78F7EA67-264C-4C9F-97B2-C3B63AC4B763Q38399867-71232333-C79A-42F9-A8B6-0856A5588B3DQ38854820-A07DA63D-D8EC-47B4-B8E2-A29B902685CEQ38861785-A3163CFC-ECE0-4B9C-93E7-A21820F6ABF2Q39354803-5560A2C9-E11E-4108-B18C-F3187CC0296CQ39477719-7A07A8A0-0D77-4737-9605-AD23B9D77FA9Q39716581-16D7F507-A375-4E23-BC9B-1D26A19B72F8Q39896304-63BCBCA9-5227-435F-B0E8-8D75CD86BDC0Q40249489-ECD4B7A3-FB78-4A8E-AF98-3084456A6888Q40689903-F293AF0E-3F08-44E0-AAB7-B62684A77CE6Q42285993-9A92C11D-B2B3-41F5-A4A1-7034E0FF4718Q42634935-D53F6FED-90C3-4D49-94A4-72AB28B256BDQ43696881-91F52280-DAD6-42A6-8A8D-A3AA643895C8Q44053430-E125337B-7C85-42A9-B3A4-D69E1F44AE83Q44575655-90D934DF-869E-4190-ADB2-AF25FCE38800Q44998406-38A0608F-192A-495F-B53A-C7FF6E168BB1Q45239155-F8D455F9-4049-44E1-A999-026AC978307DQ46035313-A37DFE48-0009-44FE-9E6E-9528942AAA12Q48087063-6743A9F8-36F6-4F92-BE81-D0FF80473E84Q50138931-6DB54F35-E987-42E1-89F7-FD5F9E782929Q51017842-6397E905-6A50-42ED-85CA-D60A8E72133FQ51029371-4B46F93C-07E1-413B-8771-C35681D2D554Q51650158-C26B8E85-7CD8-4BB7-9C17-6651B724B1B4Q51759990-7CA3CCAE-324F-4A56-869B-76CA29987572Q53080453-74CDDF24-7BED-480D-BFF9-143C6E36BA85
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Christopher Kabrhel
@ast
Christopher Kabrhel
@en
Christopher Kabrhel
@es
Christopher Kabrhel
@nl
Christopher Kabrhel
@sl
type
label
Christopher Kabrhel
@ast
Christopher Kabrhel
@en
Christopher Kabrhel
@es
Christopher Kabrhel
@nl
Christopher Kabrhel
@sl
prefLabel
Christopher Kabrhel
@ast
Christopher Kabrhel
@en
Christopher Kabrhel
@es
Christopher Kabrhel
@nl
Christopher Kabrhel
@sl
P106
P21
P31
P496
0000-0002-8699-7176